Bempedoic acid, a component of nexlizet, is indicated: €¢ to reduce the risk of major adverse cardiovascular events (cardiovascular death, myocardial infarction, stroke, or coronary … Is nexlizet right for you?

The most common adverse reactions in the cardiovascular outcomes trial for bempedoic acid, a component of nexlizet and nexletol, at an incidence of ≥2% and 0. 5% greater than placebo …